Molecular Neurobiology of Depression: PET Findings on the Elusive Correlation with Symptom Severity
Authors:
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 4, 32816
Abstract
Molecular mechanisms in the brain are assumed to cause the symptoms and severity of neuropsychiatric disorders. This review concerns the elusive nature of relationships between the severity of depressive disorders and neuromolecular processes studied by positron emission tomography (PET). Recent PET studies of human depression have focused on serotonergic, dopaminergic, muscarinic, nicotinic, and GABAergic receptors, as well as central processes dependent on monoamine oxidase, phosphodiesterase type 4, amyloid plaques, neurofibrillar tangles, and P-glycoprotein. We find that reliable causal links between neuromolecular mechanisms and relief from depressive disorders have yet to be convincingly demonstrated. This situation may contribute to the currently limited use of PET for exploring the neuropathways that are currently viewed as being responsible for beneficial effects of antidepressant treatment regimes.Keywords
This publication has 94 references indexed in Scilit:
- Erroneous analyses of interactions in neuroscience: a problem of significanceNature Neuroscience, 2011
- Central serotonin transporter levels are associated with stress hormone response and anxietyPsychopharmacology, 2010
- Targeting Aβ and tau in Alzheimer's disease, an early interim reportExperimental Neurology, 2010
- Reduced ventral striatal/ventral pallidal serotonin1B receptor binding potential in major depressive disorderPsychopharmacology, 2010
- Depression and Alzheimer's disease: Neurobiological links and common pharmacological targetsEuropean Journal of Pharmacology, 2010
- Molecular tools for assessing human depression by positron emission tomographyEuropean Neuropsychopharmacology, 2009
- High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter bindingNeuroImage, 2009
- Elevated Serotonin Transporter Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]DASB; Comparison with Bipolar DisorderBiological Psychiatry, 2007
- Reduced Muscarinic Type 2 Receptor Binding in Subjects With Bipolar DisorderArchives of General Psychiatry, 2006
- PET evaluation of the uptake of N-[11C]methyl CP-643,051, an NK1 receptor antagonist, in the living porcine brainNuclear Medicine and Biology, 2004